Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / South Africa

Peptide legality · South Africa · updated 2026-09-22

Are peptides legal in South Africa?

Restricted

Peptides are legal in South Africa only as SAHPRA-registered prescription medicines (such as semaglutide, tirzepatide and somatropin); unregistered research or compounded peptides like BPC-157, TB-500 and compounded GLP-1s cannot lawfully be sold for human use and are the subject of active SAHPRA enforcement in 2025-2026.

Legal status overview

Peptides are restricted in South Africa: they may be sold and used only if the specific product is registered with SAHPRA as a medicine, in which case therapeutic peptides are prescription-only. There is no peptide-specific statute; instead peptides fall under the general framework of the Medicines and Related Substances Act 101 of 1965, administered by the South African Health Products Regulatory Authority (SAHPRA), which requires any product intended to treat, prevent or alter bodily function to be registered before sale. SAHPRA and the South African Pharmacy Council have moved to active enforcement, seizing unregistered compounded GLP-1 stock and moving to declare compounded GLP-1 medicines 'undesirable'.

Key points

  • In South Africa, any product intended to treat, prevent or alter bodily functions must be registered with SAHPRA under the Medicines and Related Substances Act 101 of 1965 before it can be lawfully sold, which captures peptide products marketed for therapeutic effect. [1]
  • SAHPRA warns the South African public against using unregistered peptides sold through social media, online vendors, gyms or informal suppliers, noting that powder-form peptides are not registered and that registered GLP-1 products are supplied only as ready-to-use pens or vials. [1]
  • SAHPRA has approved only three injectable GLP-1 medicines in South Africa (liraglutide, semaglutide and tirzepatide), and because semaglutide remains under patent with no licences issued to other importers, all compounded GLP-1 products containing that ingredient are illegal. [5]
  • On 5 March 2025 SAHPRA issued a Communication to Stakeholders (RC03) stating its intention to declare compounded GLP-1 and GLP-1/GIP agonist medicines 'undesirable' under Section 23 of the Medicines Act, after which no person may sell any such declared medicine. [3]
  • SAHPRA and the South African Pharmacy Council conducted a major enforcement action in Pretoria on 23 May 2026, seizing all finished products containing semaglutide, tirzepatide and related combinations at a compounding pharmacy and ordering a full product recall. [2]
  • Personal importation of unregistered medicines into South Africa is prohibited without prior SAHPRA authorisation, as its guideline states that no person may order any medicine from abroad for personal use unless SAHPRA has granted a Section 21 authorisation. [4]
  • SAHPRA's GLP-1 crackdown documented offences including illegal importation of active pharmaceutical ingredients, absence of analytical testing for identity, potency and purity, and inadequate sterile manufacturing conditions, working with the SAPC and referring supply-chain risks to SARS and Customs. [2]

Compound-by-compound status

Semaglutide (GLP-1, Ozempic®/Wegovy®)Semaglutide is legal in South Africa only as a SAHPRA-registered, prescription-only injectable pen or vial; compounded semaglutide is illegal because the drug remains under patent with no licences issued to other importers or compounders. [5]
Tirzepatide (GLP-1/GIP, Mounjaro®/Zepbound®)Tirzepatide is legal in South Africa only as a SAHPRA-approved, prescription-only medicine, and compounded tirzepatide products have been seized as unregistered and unlawful in SAHPRA's 2026 enforcement action. [2]
HGH / somatropinHuman growth hormone (somatropin) is legal in South Africa as a registered, prescription-only medicine, with multiple somatropin products approved in the national medicines register. [7]
BPC-157BPC-157 is not a SAHPRA-registered medicine in South Africa, so as an unregistered peptide sold for human use it falls under the general prohibition on selling unregistered products with therapeutic effect; no SAHPRA scheduling entry or enforcement notice naming BPC-157 individually was located. (no source found)
TB-500 (thymosin beta-4)TB-500 is not a SAHPRA-registered medicine in South Africa and is treated as an unregistered research peptide that may not lawfully be sold for human use; no South Africa source naming TB-500 specifically was found, so this reflects inference from the general medicines rule rather than a compound-specific source. (no source found)

Frequently asked questions

Can I buy peptides in South Africa without a prescription?

No lawful over-the-counter market exists for therapeutic peptides in South Africa: any peptide sold for a therapeutic effect must be a SAHPRA-registered medicine, and registered therapeutic peptides such as semaglutide are prescription-only, while unregistered research peptides sold online, in gyms or as powders may not lawfully be sold at all. [1]

Can I import peptides into South Africa for personal use?

Generally no, importing unregistered medicines into South Africa for personal use is prohibited unless SAHPRA has granted a Section 21 authorisation in advance, per SAHPRA's importation guideline. [4]

Are compounded weight-loss injections (Ozempic®/Mounjaro® copies) legal in South Africa?

No, compounded GLP-1 weight-loss injections are illegal in South Africa; SAHPRA and the SAPC seized unregistered compounded semaglutide and tirzepatide stock in a May 2026 Pretoria raid, and SAHPRA has moved to declare compounded GLP-1 medicines 'undesirable' under Section 23 of the Medicines Act. [2]

What happens to pharmacies or sellers caught selling unregistered peptides in South Africa?

In South Africa, SAHPRA and the South African Pharmacy Council can seize stock, order product recalls and pursue regulatory action; their 2026 GLP-1 enforcement cited illegal API importation, lack of analytical testing and unsafe manufacturing as grounds for seizing an entire stockpile. [2]

Is BPC-157 legal to buy in South Africa?

BPC-157 is not a SAHPRA-registered medicine in South Africa, so selling it for human use falls under the general prohibition on unregistered therapeutic products; note that no SAHPRA notice naming BPC-157 specifically was located, so its restricted status is inferred from the general medicines framework rather than a compound-specific source. (no source found)

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in South Africa, consult a licensed attorney or the national regulator.